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more than a cause. However, Thayer JF (Thayer and Lane, 2007) has
shown that decreased vagal function precedes the development of a num-
ber of risk factors for cardiovascular disease and that modiﬁcation of risk
proﬁles in the direction of lower risk is associated with increased vagal
function. Vagal tone is explored via the cardiac vagal tone by means of
heart rate variability (HRV) measurement (Task Force, 1996). HRV is aIn this issue of EBioMedicine, Koopman et al. report that autonomic
dysfunction precedes the development of rheumatoid arthritis (RA)
(Koopman et al., 2016). They observe lower parasympathetic activity,
and a decreased expression level of the parasympathetic α7nicotinic
acetylcholine receptor (α7nAChR) on peripheral blood monocytes,
and higher sympathetic hormone (norepinephrine) in patients at risk
to develop RA. Their interpretation is that autonomic dysfunction
would play a role in the etiopathogenesis of RA rather than being the re-
sult of chronic inﬂammation.
The autonomic nervous system (ANS) is the bidirectional link between
the central nervous system and the rest of the organism. The ANS is com-
posed of the sympathetic and the parasympathetic nervous system, i.e. the
vagus nerves (VN), the largest visceral sensory nerves in the body, and the
sacral parasympathetic nucleus. These are mixed nerves containing 80–
90% of afferent ﬁbres for the VN and 50% of afferent ﬁbres for the sympa-
thetic nervous system. Vagal afferents end in the nucleus tractus solitarius,
in the medulla, while sympathetic afferents end in the spinal cord. From
there, projections reach the central autonomic nervous system (CAN)
which integrates and modulates afferent information from the organism
in brain regions involved in the autonomic, endocrine, motor, and behav-
ioral responses such as the hypothalamus, the limbic system, and the pre-
frontal cortex (Benarroch, 1993). In return, the CAN generates autonomic
responses via projections to preganglionic sympathetic neurons in the spi-
nal cord and parasympathetic neurons of the dorsal motor nucleus of the
VN in the medulla to modulate the ANS and thus the vagal tone. The
CAN is sensitive to interoceptive (from the inner medium) or exterocep-
tive (environmental) information and chronic activation of the CAN is
able to generate dysautonomia.
There is normally a balance between the parasympathetic and sympa-
thetic nervous systems. An imbalance of the ANShas beendescribed in RA,
inﬂammatory bowel disease (IBD) (Pellissier et al., 2010), and others.om.2016.02.029.
. This is an open access article underGenerally, this imbalance is interpreted as a consequence of the disease
marker of the sympatho-vagal balance where the LF/HF ratio is calculated
as a global marker of the autonomic balance where LF (low frequency)
represents the sympathetic tone and HF (high frequency) the parasympa-
thetic (i.e. vagal) tone. The cardiac vagal tone and HRV have allowed the
construction of the neurovisceral integration model that includes the
CAN.AdecreasedHRVat rest reﬂects a lowvagal tone and couldbe consid-
ered as a marker of stress. A high level of HRV is associated with good
health and well-being and good resilience in emotional self-regulation.
HRV may be a novel, useful predictor of response to anti-TNF therapy in
patients with inﬂammatory arthritis and others, and emphasizes the im-
portance of autonomic inﬂuence of autoimmune disease expression. The
prefrontal cortex regulates peripheral immune cells through the autonom-
ic and neuroendocrine pathways and controls vagal tone by modulating
the VN efferent outﬂow. Increased inﬂammatory markers, e.g. C reactive
protein and interleukin-6, are associatedwithdecreasedHRV.Wehavede-
scribed an imbalance between the hypothalamic pituitary adrenal (HPA)
axis and vagal tone in Crohn's disease patients and highlighted the speciﬁc
homeostatic link between a low vagal tone and TNFα in these patients
(Pellissier et al., 2014).
The VN has a dual anti-inﬂammatory effect both through its afferent
ﬁbers activating the HPA axis and, more recently, through its efferent ﬁ-
bres, i.e. the cholinergic anti-inﬂammatory pathway (CAP) where ACh
inhibits the release of TNFα by macrophages after binding to
α7nAChR (Pavlov and Tracey, 2015). A vago-sympathetic pathway
where the VN stimulates the splenic nerve thus inhibiting the release
of TNFα by spleen macrophages has been evoked (Pavlov and Tracey,
2015) but debated by others. There is very few data, except in the car-
diovascular domain, regarding the fact that autonomic dysfunction pre-
cedes inﬂammatory diseases. Low vagal tone is a signiﬁcant predictor of
necrotizing enterocolitis in pre-term infants (Doheny et al., 2014). The
present results of Koopman et al. are very important since one can imag-
ine that restoring a normal vagal tone by targeting the CAP could either
prevent the development of inﬂammatory disorders such as RA, IBD and
others and/or prevent a ﬂare of the disease in such patients with an im-
balance of the ANS. Among such targets could be drugs such asthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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such as galantamine, or non-drug therapies such as physical exercise,
complementary therapy such as hypnosis, cognitive behavioral thera-
pies, known to improve vagal tone. VN stimulation (VNS) either inva-
sive or non-invasive could be of interest. We have recently shown, in a
pilot study performed in patients with mild to moderate CD, that inva-
sive VNS improves these patients and restores vagal tone but further in-
vestigation is warranted (Bonaz et al., 2016). VNS studies are also
ongoing in RA (Koopman et al., 2012). Ideally, a chronic recording of
vagal tone in patients susceptible to develop inﬂammatory disorders
would be of interest. In the same way, a technique which could restore
vagal tone based on this recording would be of interest.
As stated by the authors, identiﬁcation of additional risk factors for
RA is necessary to provide insight into pathogenic mechanisms contrib-
uting to the development of clinically manifest disease, and might also
lead to development of novel preventive strategies. The characteriza-
tion of the sympathovagal balance would be of interest in RA, but also
other inﬂammatory disorders, such as IBD. This parameter should be
part of the evaluation of these patients in addition to clinical, biological
(inﬂammatory), and morphological parameters.
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